New Test Predicts Survival in Early-Stage Lung Cancer Better than Current Methods
Researchers at the Francis Crick Institute and University College London (UCL) Cancer Institute have demonstrated that a test called the ORACLE can better predict clinical outcomes for patients with early-stage lung cancer than current methods.
